117 related articles for article (PubMed ID: 12190879)
1. p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization.
Stern RS; Bolshakov S; Nataraj AJ; Ananthaswamy HN
J Invest Dermatol; 2002 Aug; 119(2):522-6. PubMed ID: 12190879
[TBL] [Abstract][Full Text] [Related]
2. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
[TBL] [Abstract][Full Text] [Related]
3. The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients.
Wolf P; Kreimer-Erlacher H; Seidl H; Bäck B; Soyer HP; Kerl H
J Invest Dermatol; 2004 Jan; 122(1):190-200. PubMed ID: 14962108
[TBL] [Abstract][Full Text] [Related]
4. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
Kreimer-Erlacher H; Seidl H; Bäck B; Cerroni L; Kerl H; Wolf P
J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
[TBL] [Abstract][Full Text] [Related]
5. p53 mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA).
Nataraj AJ; Wolf P; Cerroni L; Ananthaswamy HN
J Invest Dermatol; 1997 Aug; 109(2):238-43. PubMed ID: 9242514
[TBL] [Abstract][Full Text] [Related]
6. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients.
Kreimer-Erlacher H; Seidl H; Bäck B; Kerl H; Wolf P
Photochem Photobiol; 2001 Aug; 74(2):323-30. PubMed ID: 11547572
[TBL] [Abstract][Full Text] [Related]
7. Green tea protects against psoralen plus ultraviolet A-induced photochemical damage to skin.
Zhao JF; Zhang YJ; Jin XH; Athar M; Santella RM; Bickers DR; Wang ZY
J Invest Dermatol; 1999 Dec; 113(6):1070-5. PubMed ID: 10594754
[TBL] [Abstract][Full Text] [Related]
8. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
Nijsten TE; Stern RS
J Invest Dermatol; 2003 Aug; 121(2):252-8. PubMed ID: 12880415
[TBL] [Abstract][Full Text] [Related]
9. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
Gasparro FP
Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
[TBL] [Abstract][Full Text] [Related]
10. Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: the role of molecular epidemiology in minimizing risks.
Gasparro FP; Liao B; Foley PJ; Wang XM; McNiff JM
Environ Mol Mutagen; 1998; 31(2):105-12. PubMed ID: 9544188
[TBL] [Abstract][Full Text] [Related]
11. Carcinogenicity of combined ultraviolet B radiation and psoralen plus ultraviolet A irradiation treatment of mice.
Granstein RD; Morison WL; Kripke ML
Photodermatol Photoimmunol Photomed; 1992-1993 Oct; 9(5):198-202. PubMed ID: 1342188
[TBL] [Abstract][Full Text] [Related]
12. An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with PUVA.
Wang XM; McNiff JM; Klump V; Asgari M; Gasparro FP
Photochem Photobiol; 1997 Aug; 66(2):294-9. PubMed ID: 9277151
[TBL] [Abstract][Full Text] [Related]
13. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
Stern RS;
J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization.
Kanjilal S; Strom SS; Clayman GL; Weber RS; el-Naggar AK; Kapur V; Cummings KK; Hill LA; Spitz MR; Kripke ML
Cancer Res; 1995 Aug; 55(16):3604-9. PubMed ID: 7627969
[TBL] [Abstract][Full Text] [Related]
15. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
Henseler T; Christophers E
Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
[TBL] [Abstract][Full Text] [Related]
16. Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers.
Nataraj AJ; Black HS; Ananthaswamy HN
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7961-5. PubMed ID: 8755585
[TBL] [Abstract][Full Text] [Related]
17. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
Stern RS; Bagheri S; Nichols K;
J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
[TBL] [Abstract][Full Text] [Related]
18. Detection of human papillomavirus DNA in PUVA-associated non-melanoma skin cancers.
Harwood CA; Spink PJ; Surentheran T; Leigh IM; Hawke JL; Proby CM; Breuer J; McGregor JM
J Invest Dermatol; 1998 Jul; 111(1):123-7. PubMed ID: 9665398
[TBL] [Abstract][Full Text] [Related]
19. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
Harnes DK; Thune P
Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
[TBL] [Abstract][Full Text] [Related]
20. Multiple nonmelanoma skin cancers in a patient with epidermolytic hyperkeratosis on long-standing retinoid therapy.
Sarnoff DS; Saini R
J Drugs Dermatol; 2008 May; 7(5):475-8. PubMed ID: 18505142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
